Be a PRO & get up to 50% off on select brands. Explore Now
you are here: HomeNewsIndia

Coronavirus pandemic | India likely to witness wave of peaks in COVID-19 cases: Report

Experts suggest that the wave of peaks in COVID-19 cases in India could happen in the next two months as infections are spreading at varied pace in different states and Union Territories.

July 20, 2020 / 09:25 AM IST

India is likely to witness a wave of peaks in COVID-19 cases across the country instead of one high, according to a report by the Business Standard. This is because infections from the novel coronavirus are spreading at varied pace in different states and Union Territories (UTs).

The report quotes Bhramar Mukherjee, professor of epidemiology, Michigan University, as saying that this wave of peaks could happen in the next two months.

Earlier, some experts had predicted that a nationwide peak in daily cases could be seen in late July-early August. However, the report cites epidemiologists as suggesting that the concept of a national peak is hazy.

Follow our LIVE blog for the latest updates of the novel coronavirus pandemic

Maharashtra, Tamil Nadu and Delhi – which have recorded the highest number of confirmed COVID-19 cases so far, have been showing signs of slowing down. However, cases are now spiking consistently in southern and eastern states.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

Also Read: Why cases in India are rising to multiple peaks

India has so far reported over 10.7 lakh COVID-19 cases, including 26,816 deaths. The nationwide recovery rate of COVID-19 patients has risen to around 63 percent. However, the country has been recording record single-day spikes in the last couple of weeks.

Speaking to news agency PTI, Professor K Srinath Reddy, President of Public Health Foundation of India, had earlier said that COVID-19 cases may peak in India as early as mid-September provided strong public health measures are in place and people behave in a responsible manner to contain the virus.

Click here for Moneycontrol’s full coverage of the novel coronavirus pandemic
Moneycontrol News
first published: Jul 20, 2020 09:25 am

stay updated

Get Daily News on your Browser